RhumbLine Advisers’s CareTrust REIT CTRE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $29.5M | Buy |
730,731
+43,598
| +6% | +$1.71M | 0.02% | 574 |
|
|
2026
Q1 | $25.2M | Buy |
687,133
+76,048
| +12% | +$2.92M | 0.02% | 610 |
|
|
2025
Q4 | $22.1M | Sell |
611,085
-38,590
| -6% | -$1.38M | 0.02% | 671 |
|
|
2025
Q3 | $22.5M | Buy |
649,675
+60,604
| +10% | +$1.99M | 0.02% | 671 |
|
|
2025
Q2 | $18M | Buy |
589,071
+31,891
| +6% | +$920K | 0.02% | 763 |
|
|
2025
Q1 | $15.9M | Sell |
557,180
-15,484
| -3% | -$416K | 0.01% | 807 |
|
|
2024
Q4 | $15.5M | Buy |
572,664
+121,328
| +27% | +$3.62M | 0.01% | 832 |
|
|
2024
Q3 | $13.9M | Buy |
451,336
+12,144
| +3% | +$344K | 0.01% | 901 |
|
|
2024
Q2 | $11M | Buy |
439,192
+42,677
| +11% | +$1.06M | 0.01% | 980 |
|
|
2024
Q1 | $9.66M | Buy |
396,515
+39,017
| +11% | +$881K | 0.01% | 1060 |
|
|
2023
Q4 | $8M | Buy |
357,498
+27,480
| +8% | +$608K | 0.01% | 1163 |
|
|
2023
Q3 | $6.77M | Sell |
330,018
-8,814
| -3% | -$178K | 0.01% | 1185 |
|
|
2023
Q2 | $6.73M | Buy |
338,832
+2,600
| +0.8% | +$50.8K | 0.01% | 1209 |
|
|
2023
Q1 | $6.58M | Buy |
336,232
+25,450
| +8% | +$498K | 0.01% | 1175 |
|
|
2022
Q4 | $5.77M | Buy |
310,782
+1,096
| +0.4% | +$20.5K | 0.01% | 1202 |
|
|
2022
Q3 | $5.61M | Buy |
309,686
+11,510
| +4% | +$235K | 0.01% | 1159 |
|
|
2022
Q2 | $5.5M | Buy |
298,176
+8,818
| +3% | +$156K | 0.01% | 1190 |
|
|
2022
Q1 | $5.58M | Buy |
289,358
+3,062
| +1% | +$60.4K | 0.01% | 1242 |
|
|
2021
Q4 | $6.54M | Sell |
286,296
-2,150
| -0.7% | -$45.5K | 0.01% | 1217 |
|
|
2021
Q3 | $5.86M | Sell |
288,446
-64,139
| -18% | -$1.45M | 0.01% | 1262 |
|
|
2021
Q2 | $8.19M | Sell |
352,585
-5,400
| -2% | -$127K | 0.01% | 1125 |
|
|
2021
Q1 | $8.34M | Buy |
357,985
+29,330
| +9% | +$673K | 0.01% | 1108 |
|
|
2020
Q4 | $7.29M | Buy |
328,655
+17,863
| +6% | +$352K | 0.01% | 1126 |
|
|
2020
Q3 | $5.53M | Sell |
310,792
-23,552
| -7% | -$428K | 0.01% | 1103 |
|
|
2020
Q2 | $5.74M | Sell |
334,344
-618
| -0.2% | -$10.8K | 0.01% | 1123 |
|
|
2020
Q1 | $4.95M | Buy |
334,962
+6,867
| +2% | +$136K | 0.01% | 1033 |
|
|
2019
Q4 | $6.77M | Buy |
328,095
+22,991
| +8% | +$503K | 0.01% | 1075 |
|
|
2019
Q3 | $7.17M | Buy |
305,104
+11,248
| +4% | +$264K | 0.01% | 974 |
|
|
2019
Q2 | $6.99M | Buy |
293,856
+20,678
| +8% | +$501K | 0.01% | 995 |
|
|
2019
Q1 | $6.41M | Buy |
273,178
+16,129
| +6% | +$353K | 0.01% | 1033 |
|
|
2018
Q4 | $4.75M | Buy |
257,049
+51,449
| +25% | +$958K | 0.01% | 1139 |
|
|
2018
Q3 | $3.64M | Sell |
205,600
-9,418
| -4% | -$166K | 0.01% | 1316 |
|
|
2018
Q2 | $3.59M | Buy |
215,018
+27,325
| +15% | +$411K | 0.01% | 1327 |
|
|
2018
Q1 | $2.52M | Buy |
187,693
+5,171
| +3% | +$76.5K | 0.01% | 1476 |
|
|
2017
Q4 | $3.06M | Buy |
182,522
+25,943
| +17% | +$480K | 0.01% | 1367 |
|
|
2017
Q3 | $2.98M | Buy |
156,579
+4,924
| +3% | +$92.2K | 0.01% | 1353 |
|
|
2017
Q2 | $2.81M | Buy |
151,655
+18,736
| +14% | +$339K | 0.01% | 1356 |
|
|
2017
Q1 | $2.24M | Buy |
132,919
+45,592
| +52% | +$708K | 0.01% | 1483 |
|
|
2016
Q4 | $1.34M | Buy |
87,327
+10,649
| +14% | +$152K | ﹤0.01% | 1681 |
|
|
2016
Q3 | $1.13M | Buy |
76,678
+5,215
| +7% | +$76.5K | ﹤0.01% | 1741 |
|
|
2016
Q2 | $985K | Buy |
71,463
+11,537
| +19% | +$152K | ﹤0.01% | 1792 |
|
|
2016
Q1 | $761K | Buy |
59,926
+2,300
| +4% | +$25.5K | ﹤0.01% | 1967 |
|
|
2015
Q4 | $631K | Buy |
57,626
+8,905
| +18% | +$98.4K | ﹤0.01% | 2099 |
|
|
2015
Q3 | $553K | Buy |
48,721
+12,369
| +34% | +$150K | ﹤0.01% | 2159 |
|
|
2015
Q2 | $461K | Sell |
36,352
-2,365
| -6% | -$30.9K | ﹤0.01% | 2385 |
|
|
2015
Q1 | $525K | Buy |
38,717
+8,806
| +29% | +$114K | ﹤0.01% | 2276 |
|
|
2014
Q4 | $369K | Buy |
29,911
+7,587
| +34% | +$112K | ﹤0.01% | 2460 |
|
|
2014
Q3 | $319K | Buy |
22,324
+1,200
| +6% | +$20.3K | ﹤0.01% | 2488 |
|
|
2014
Q2 | $418K | Buy |
+21,124
| New | +$386K | ﹤0.01% | 2388 |
|
Other funds holding CTRE
RhumbLine Advisers's CTRE Position: Q2 2026 in Review
RhumbLine Advisers increased its CareTrust REIT (CTRE) stake by 6.3% in Q2 2026, buying an estimated $1.71M and bringing the position to 730,731 shares worth $29.5M. The position accounts for 0.02% of the portfolio, ranked #574.
RhumbLine Advisers first reported a position in CTRE in Q2 2014 and has held it in 49 quarters since. 512 funds tracked by Wall St. Rank hold CTRE as of Q2 2026.
- RhumbLine Advisers held 730,731 shares of CareTrust REIT worth $29.5M as of Q2 2026.
- RhumbLine Advisers bought 43,598 CareTrust REIT shares in Q2 2026, an estimated $1.71M.
- CareTrust REIT made up 0.02% of RhumbLine Advisers's portfolio in Q2 2026, its #574 holding.
- RhumbLine Advisers first reported a position in CareTrust REIT in Q2 2014 and has held it in 49 quarters since.
- 512 funds tracked by Wall St. Rank held CareTrust REIT as of Q2 2026.
Based on RhumbLine Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.